{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "import camelot\n",
    "tables = camelot.read_pdf('docs/Keytruda PI.pdf',pages=\"8\", flag_size=True,shift_text=['/n'])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>1</th>\n",
       "      <th>2</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Indication</td>\n",
       "      <td>Recommended Dosage of\\n \\nKEYTRUDA</td>\n",
       "      <td>Duration/Timing of Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Monotherapy</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Adult patients with unresectable or \\nmetastat...</td>\n",
       "      <td>200 mg every 3 weeks* \\nor \\n400 mg every 6 we...</td>\n",
       "      <td>Until disease progression or \\nunacceptable to...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Adjuvant treatment of adult patients \\nwith me...</td>\n",
       "      <td>200 mg every 3 weeks* \\nor \\n400 mg every 6 we...</td>\n",
       "      <td>Until disease recurrence, unacceptable \\ntoxic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Adult patients with NSCLC, SCLC, \\nHNSCC, cHL,...</td>\n",
       "      <td>200 mg every 3 weeks* \\nor \\n400 mg every 6 we...</td>\n",
       "      <td>Until disease progression, unacceptable \\ntoxi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Adult patients with high-risk BCG-\\nunresponsi...</td>\n",
       "      <td>200 mg every 3 weeks* \\nor \\n400 mg every 6 we...</td>\n",
       "      <td>Until persistent or recurrent high-risk \\nNMIB...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Pediatric patients with cHL, PMBCL, \\nMSI-H Ca...</td>\n",
       "      <td>2 mg/kg every 3 weeks (up to a \\nmaximum of 20...</td>\n",
       "      <td>Until disease progression, unacceptable \\ntoxi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Combination Therapy&lt;s&gt;† &lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Adult patients with NSCLC, HNSCC, or \\nEsophag...</td>\n",
       "      <td>200 mg every 3 weeks* \\nor \\n400 mg every 6 we...</td>\n",
       "      <td>Until disease progression, unacceptable \\ntoxi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Adult patients with RCC</td>\n",
       "      <td>200 mg every 3 weeks* \\nor \\n400 mg every 6 we...</td>\n",
       "      <td>Until disease progression, unacceptable \\ntoxi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Adult patients with Endometrial \\nCarcinoma</td>\n",
       "      <td>200 mg every 3 weeks* \\nor \\n400 mg every 6 we...</td>\n",
       "      <td>Until disease progression, unacceptable \\ntoxi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Adult patients with locally recurrent \\nunrese...</td>\n",
       "      <td>200 mg every 3 weeks* \\nor \\n400 mg every 6 we...</td>\n",
       "      <td>Until disease progression, unacceptable \\ntoxi...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    0  \\\n",
       "0                                          Indication   \n",
       "1                                         Monotherapy   \n",
       "2   Adult patients with unresectable or \\nmetastat...   \n",
       "3   Adjuvant treatment of adult patients \\nwith me...   \n",
       "4   Adult patients with NSCLC, SCLC, \\nHNSCC, cHL,...   \n",
       "5   Adult patients with high-risk BCG-\\nunresponsi...   \n",
       "6   Pediatric patients with cHL, PMBCL, \\nMSI-H Ca...   \n",
       "7                        Combination Therapy<s>† </s>   \n",
       "8   Adult patients with NSCLC, HNSCC, or \\nEsophag...   \n",
       "9                             Adult patients with RCC   \n",
       "10        Adult patients with Endometrial \\nCarcinoma   \n",
       "11  Adult patients with locally recurrent \\nunrese...   \n",
       "\n",
       "                                                    1  \\\n",
       "0                  Recommended Dosage of\\n \\nKEYTRUDA   \n",
       "1                                                       \n",
       "2   200 mg every 3 weeks* \\nor \\n400 mg every 6 we...   \n",
       "3   200 mg every 3 weeks* \\nor \\n400 mg every 6 we...   \n",
       "4   200 mg every 3 weeks* \\nor \\n400 mg every 6 we...   \n",
       "5   200 mg every 3 weeks* \\nor \\n400 mg every 6 we...   \n",
       "6   2 mg/kg every 3 weeks (up to a \\nmaximum of 20...   \n",
       "7                                                       \n",
       "8   200 mg every 3 weeks* \\nor \\n400 mg every 6 we...   \n",
       "9   200 mg every 3 weeks* \\nor \\n400 mg every 6 we...   \n",
       "10  200 mg every 3 weeks* \\nor \\n400 mg every 6 we...   \n",
       "11  200 mg every 3 weeks* \\nor \\n400 mg every 6 we...   \n",
       "\n",
       "                                                    2  \n",
       "0                        Duration/Timing of Treatment  \n",
       "1                                                      \n",
       "2   Until disease progression or \\nunacceptable to...  \n",
       "3   Until disease recurrence, unacceptable \\ntoxic...  \n",
       "4   Until disease progression, unacceptable \\ntoxi...  \n",
       "5   Until persistent or recurrent high-risk \\nNMIB...  \n",
       "6   Until disease progression, unacceptable \\ntoxi...  \n",
       "7                                                      \n",
       "8   Until disease progression, unacceptable \\ntoxi...  \n",
       "9   Until disease progression, unacceptable \\ntoxi...  \n",
       "10  Until disease progression, unacceptable \\ntoxi...  \n",
       "11  Until disease progression, unacceptable \\ntoxi...  "
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tables[0].df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "import camelot\n",
    "tables = camelot.read_pdf('docs/Keytruda PI.pdf',pages=\"9\", copy_text=['v'], flag_size=True,shift_text=['/n'],process_background=False,line_scale=5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>1</th>\n",
       "      <th>2</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Adverse Reaction</td>\n",
       "      <td>Severity*</td>\n",
       "      <td>Dosage Modification</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Immune-Mediated Adverse Reactions [see Warning...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td>Grade 2</td>\n",
       "      <td>Withhold&lt;s&gt;† &lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Pneumonitis</td>\n",
       "      <td>Grade 3 or 4</td>\n",
       "      <td>Permanently discontinue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td></td>\n",
       "      <td>Grade 2 or 3</td>\n",
       "      <td>Withhold&lt;s&gt;† &lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Colitis</td>\n",
       "      <td>Grade 4</td>\n",
       "      <td>Permanently discontinue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Hepatitis with no tumor involvement \\nof the l...</td>\n",
       "      <td>AST or ALT increases to more than 3 \\nand up t...</td>\n",
       "      <td>Withhold&lt;s&gt;† &lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>For liver enzyme elevations in \\npatients trea...</td>\n",
       "      <td>AST or ALT increases to more than \\n8 times UL...</td>\n",
       "      <td>Permanently discontinue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Hepatitis with tumor involvement of \\nthe live...</td>\n",
       "      <td>Baseline AST or ALT is more than 1 \\nand up to...</td>\n",
       "      <td>Withhold&lt;s&gt;† &lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Hepatitis with tumor involvement of \\nthe live...</td>\n",
       "      <td>ALT or AST increases to more than \\n10 times U...</td>\n",
       "      <td>Permanently discontinue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Endocrinopathies</td>\n",
       "      <td>Grade 3 or 4</td>\n",
       "      <td>Withhold until clinically stable or permanentl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td></td>\n",
       "      <td>Grade 2 or 3 increased blood creatinine</td>\n",
       "      <td>Withhold&lt;s&gt;† &lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Nephritis with Renal Dysfunction</td>\n",
       "      <td>Grade 4 increased blood creatinine</td>\n",
       "      <td>Permanently discontinue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Exfoliative Dermatologic Conditions</td>\n",
       "      <td>Suspected SJS, TEN, or DRESS</td>\n",
       "      <td>Withhold&lt;s&gt;† &lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Exfoliative Dermatologic Conditions</td>\n",
       "      <td>Confirmed SJS, TEN, or DRESS</td>\n",
       "      <td>Permanently discontinue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Myocarditis</td>\n",
       "      <td>Grade 2, 3, or 4</td>\n",
       "      <td>Permanently discontinue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td></td>\n",
       "      <td>Grade 2</td>\n",
       "      <td>Withhold&lt;s&gt;† &lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Neurological Toxicities</td>\n",
       "      <td>Grade 3 or 4</td>\n",
       "      <td>Permanently discontinue</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Hematologic toxicity in patients with \\ncHL or...</td>\n",
       "      <td>Grade 4</td>\n",
       "      <td>Withhold until resolution to Grades 0 or 1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    0  \\\n",
       "0                                    Adverse Reaction   \n",
       "1   Immune-Mediated Adverse Reactions [see Warning...   \n",
       "2                                                       \n",
       "3                                         Pneumonitis   \n",
       "4                                                       \n",
       "5                                             Colitis   \n",
       "6   Hepatitis with no tumor involvement \\nof the l...   \n",
       "7   For liver enzyme elevations in \\npatients trea...   \n",
       "8   Hepatitis with tumor involvement of \\nthe live...   \n",
       "9   Hepatitis with tumor involvement of \\nthe live...   \n",
       "10                                   Endocrinopathies   \n",
       "11                                                      \n",
       "12                   Nephritis with Renal Dysfunction   \n",
       "13                Exfoliative Dermatologic Conditions   \n",
       "14                Exfoliative Dermatologic Conditions   \n",
       "15                                        Myocarditis   \n",
       "16                                                      \n",
       "17                            Neurological Toxicities   \n",
       "18  Hematologic toxicity in patients with \\ncHL or...   \n",
       "\n",
       "                                                    1  \\\n",
       "0                                           Severity*   \n",
       "1                                                       \n",
       "2                                             Grade 2   \n",
       "3                                        Grade 3 or 4   \n",
       "4                                        Grade 2 or 3   \n",
       "5                                             Grade 4   \n",
       "6   AST or ALT increases to more than 3 \\nand up t...   \n",
       "7   AST or ALT increases to more than \\n8 times UL...   \n",
       "8   Baseline AST or ALT is more than 1 \\nand up to...   \n",
       "9   ALT or AST increases to more than \\n10 times U...   \n",
       "10                                       Grade 3 or 4   \n",
       "11            Grade 2 or 3 increased blood creatinine   \n",
       "12                 Grade 4 increased blood creatinine   \n",
       "13                       Suspected SJS, TEN, or DRESS   \n",
       "14                       Confirmed SJS, TEN, or DRESS   \n",
       "15                                   Grade 2, 3, or 4   \n",
       "16                                            Grade 2   \n",
       "17                                       Grade 3 or 4   \n",
       "18                                            Grade 4   \n",
       "\n",
       "                                                    2  \n",
       "0                                 Dosage Modification  \n",
       "1                                                      \n",
       "2                                   Withhold<s>† </s>  \n",
       "3                             Permanently discontinue  \n",
       "4                                   Withhold<s>† </s>  \n",
       "5                             Permanently discontinue  \n",
       "6                                   Withhold<s>† </s>  \n",
       "7                             Permanently discontinue  \n",
       "8                                   Withhold<s>† </s>  \n",
       "9                             Permanently discontinue  \n",
       "10  Withhold until clinically stable or permanentl...  \n",
       "11                                  Withhold<s>† </s>  \n",
       "12                            Permanently discontinue  \n",
       "13                                  Withhold<s>† </s>  \n",
       "14                            Permanently discontinue  \n",
       "15                            Permanently discontinue  \n",
       "16                                  Withhold<s>† </s>  \n",
       "17                            Permanently discontinue  \n",
       "18         Withhold until resolution to Grades 0 or 1  "
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tables[0].df"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "CHATBOT",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.1"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
